U.S. increases order of Moderna mRNA COVID-19 vaccine to 300M doses

By The Science Advisory Board staff writers

January 27, 2021 -- Moderna is in discussion with the U.S. government for the purchase of an additional 100 million doses of its messenger RNA (mRNA) COVID-19 vaccine, mRNA-1273, for delivery in the third quarter of 2021.

To date, the U.S. has agreed to purchase 200 million doses of the Moderna COVID-19 vaccine, and this new purchase would bring the total to 300 million doses. The company plans on using its U.S.-based manufacturing capabilities to supply the vaccine to the U.S. government.


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.